🔎 Trials Near Me

Utama › Makroglobulinemia Waldenstrom › Colorado

Kajian klinikal Makroglobulinemia Waldenstrom di Colorado

8 kajian untuk Makroglobulinemia Waldenstrom sedang mencari peserta di lokasi di Colorado.

Bandar di Colorado

Teks kajian rasmi (Bahasa Inggeris)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Uchealth North, Fort Collins
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05006716

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Colorado Blood Cancer Institute ( Site 2726), Denver
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
  • Colorado Blood Cancer Institute, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

  • Colorado Blood Cancer Institute (CBCI), Denver
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06561347

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • Colorado Blood Cancer Institute, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05131022

SynKIR-310 for Relapsed/Refractory B-NHL

  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Apr 2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Colorado Blood Cancer Institute, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2025 · NCT05780034

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.